Indefinite Delivery Contract 36C24625D0023
Award Date
1/1/25
Last Date to Order
12/31/28
Federal Agency
Veterans Integrated Service Network 6
Awardee
Progenics Pharmaceuticals Inc.
Ultimate Awardee
Lantheus Holdings, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The key products and services being delivered under this Blanket Purchase Agreement (BPA) federal contract Indefinite Delivery Vehicle (IDV) are PYLARIFY (piflufolastat F-18), a radiopharmaceutical drug used for positron emission tomography (PET) imaging of prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and a subsidiary of Lantheus Holdings, Inc. The contract, valued at up to $1,188,615.44, was awarded by the U.S....
The key products and services being delivered under this federal contract IDV award are radiopharmaceutical diagnostic imaging agents, specifically PYLARIFY (piflufolastat F-18), provided by Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. The Department of Veterans Affairs (VA) is the primary funding agency for this single-award Indefinite Delivery Contract, valued at $5,052,208 with a period of performance through January 31, 2030. Task orders issued under this IDV...
The key products and services being delivered under this federal contract IDV are PYLARIFY (piflufolastat F-18), a radiopharmaceutical drug used for positron emission tomography (PET) imaging of prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and a subsidiary of Lantheus Holdings, Inc. The contract vehicles include several Blanket Purchase Agreements (BPAs) awarded by the U.S. Department of Veterans Affairs (VA) and the...
This is a $2,616,322.00 Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA), specifically through Veterans Integrated Service Network (VISN) 9, to Pharmalogic Holdings Corp. (doing business as Pharmalogic Puerto Rico). The contract is for the delivery of PYLARIFY F-18 piflufolastat, a radiopharmaceutical used for prostate cancer imaging, to support the VA's nuclear medicine services and imaging programs for veterans. The contract has a 5-year performance...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., for the provision of PYLARIFY (piflufolastat F-18) injection, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The single-award BPA, valued at $2,634,365.60, was established under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has...
Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings Inc., was awarded a Blanket Purchase Agreement (BPA) by the U.S. Department of Veterans Affairs (VA) to provide PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for positron emission tomography (PET) imaging of prostate cancer. The BPA, valued at up to $5.5 million, is associated with the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and allows various VA medical facilities to issue task orders for...
The U.S. Department of Veterans Affairs (VA) has awarded Blanket Purchase Agreements (BPAs) totaling over $4.3 million to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., for the delivery of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used in positron emission tomography (PET) scans to detect prostate cancer. These BPAs, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allow various VA healthcare facilities across the Veterans...
The federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21 (VHA VISN 21) to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. The contract is for the delivery of PYLARIFY (piflufolastat F-18), a radiopharmaceutical product used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer in...
The federal contract Indefinite Delivery Vehicle (IDV) award is a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. The contract has a total ceiling value of $290,000,000 and a period of performance through March 31, 2030. The focus of this IDV contract is the delivery of Progenics'...
The Defense Health Agency (DHA) awarded a Blanket Purchase Agreement (BPA) to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., for the delivery of PYLARIFY (piflufolastat F-18) injection, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The BPA has a ceiling value of $1,000,000 and a period of performance through January 31, 2028. The contract is not set aside for small businesses. Under this BPA, the DHA...